title: A call for action--prevention of fetal exposure to isotretinoin. A position paper by The Organization of Teratology Information Services Public Affairs Committee.
authors.affiliation: Division of Clinical Pharmacology, The Hospital for Sick Children, Toronto, Ontario, Canada.
authors.forename: V
authors.initials: V
authors.lastname: Carver
authors.forename: B
authors.initials: B
authors.lastname: Coyle
authors.forename: G
authors.initials: G
authors.lastname: Koren
authors.forename: S
authors.initials: S
authors.lastname: Lavigne
authors.forename: L
authors.initials: L
authors.lastname: Martinez
authors.forename: J
authors.initials: J
authors.lastname: Robertson
authors.forename: J
authors.initials: J
authors.lastname: Polifka
authors.forename: K
authors.initials: K
authors.lastname: Stepanuk
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000209:etiology* / Q000517:prevention & control*; D000328:Adult; D000075202:Contraindications; D003879:Dermatologic Agents / Q000009:adverse effects*; D005260:Female; D014943:Global Health; D006801:Humans; D007255:Information Services; D015474:Isotretinoin / Q000009:adverse effects*; D016134:Organizational Policy; D011247:Pregnancy; D012958:Societies, Scientific; D018600:Teratology; D014481:United States
chemical_list: D003879:Dermatologic Agents; D015474:Isotretinoin